Cargando…

Mismatch Repair Status in Patient-Derived Colorectal Cancer Organoids Does Not Affect Intrinsic Tumor Cell Sensitivity to Systemic Therapy

SIMPLE SUMMARY: The large majority of patients with metastatic colorectal cancer (mCRC) receive chemotherapy with or without targeted therapy. Tumors with a deficient DNA mismatch repair (dMMR) system respond poorly to systemic therapy and are associated with poor prognosis. However, it is unclear w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Küçükköse, Emre, Wensink, G. Emerens, Roelse, Celine M., van Schelven, Susanne J., Raats, Daniëlle A. E., Boj, Sylvia F., Koopman, Miriam, Laoukili, Jamila, Roodhart, Jeanine M. L., Kranenburg, Onno
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582471/ https://www.ncbi.nlm.nih.gov/pubmed/34771595 http://dx.doi.org/10.3390/cancers13215434

Ejemplares similares

Patient-derived organoids as a predictive biomarker for treatment response in cancer patients
por: Wensink, G. Emerens, et al.
Publicado: (2021)

CD95 ligand induces senescence in mismatch repair-deficient human colon cancer via chronic caspase-mediated induction of DNA damage
por: Raats, Danielle A, et al.
Publicado: (2017)

Modeling resistance of colorectal peritoneal metastases to immune checkpoint blockade in humanized mice
por: Küçükköse, Emre, et al.
Publicado: (2022)

Co-cultures of colon cancer cells and cancer-associated fibroblasts recapitulate the aggressive features of mesenchymal-like colon cancer
por: Strating, Esther, et al.
Publicado: (2023)

KIT promotes tumor stroma formation and counteracts tumor-suppressive TGFβ signaling in colorectal cancer
por: Küçükköse, Emre, et al.
Publicado: (2022)

Survival of Patients with Deficient Mismatch Repair Versus Proficient Mismatch Repair Metastatic Colorectal Cancer Receiving Curative-Intent Local Treatment of Metastases in a Nationwide Cohort
por: Zwart, Koen, et al.
Publicado: (2023)

Loss of Neuropilin-2 in Murine Mesenchymal-like Colon Cancer Organoids Causes Mesenchymal-to-Epithelial Transition and an Acquired Dependency on Insulin-Receptor Signaling and Autophagy
por: Poghosyan, Susanna, et al.
Publicado: (2022)

Differential anti-tumour effects of MTH1 inhibitors in patient-derived 3D colorectal cancer cultures
por: van der Waals, Lizet M., et al.
Publicado: (2019)

ASO Author Reflections: Clinical Outcome After Upfront Curative-Intent Local Treatment of Metastases in Patient with Deficient Mismatch Repair Versus Proficient Mismatch Repair Metastatic Colorectal Cancer
por: Zwart, Koen, et al.
Publicado: (2023)

Downregulation of DNA repair proteins and increased DNA damage in hypoxic colon cancer cells is a therapeutically exploitable vulnerability
por: Jongen, Jennifer M. J., et al.
Publicado: (2017)

External Validation of the Colon Life Nomogram for Predicting 12-Week Mortality in Dutch Metastatic Colorectal Cancer Patients Treated with Trifluridine/Tipiracil in Daily Practice
por: Hamers, Patricia A. H., et al.
Publicado: (2022)

External Validation of Two Established Clinical Risk Scores Predicting Outcome after Local Treatment of Colorectal Liver Metastases in a Nationwide Cohort
por: Bolhuis, Karen, et al.
Publicado: (2022)

Distinct and overlapping functions of glutathione peroxidases 1 and 2 in limiting NF-κB-driven inflammation through redox-active mechanisms
por: Koeberle, Solveigh C., et al.
Publicado: (2019)

NOXA-dependent contextual synthetic lethality of BCL-XL inhibition and “osmotic reprogramming” in colorectal cancer
por: Knoll, Gertrud, et al.
Publicado: (2020)

Peritoneal metastases from colorectal cancer belong to Consensus Molecular Subtype 4 and are sensitised to oxaliplatin by inhibiting reducing capacity
por: Laoukili, Jamila, et al.
Publicado: (2022)

Predicting early extrahepatic recurrence after local treatment of colorectal liver metastases
por: Wensink, G E, et al.
Publicado: (2023)

Prognostic value of Lynch syndrome, BRAF(V600E) , and RAS mutational status in dMMR/MSI‐H metastatic colorectal cancer in a pooled analysis of Dutch and French cohorts
por: Zwart, Koen, et al.
Publicado: (2023)

Establishment of Pancreatic Organoids from Normal Tissue and Tumors
por: Driehuis, Else, et al.
Publicado: (2020)

Survival of patients with deficient mismatch repair metastatic colorectal cancer in the pre-immunotherapy era
por: Wensink, G. Emerens, et al.
Publicado: (2020)

Oncogenic K-Ras Activates p38 to Maintain Colorectal Cancer Cell Proliferation during MEK Inhibition
por: van Houdt, Winan J., et al.
Publicado: (2010)

Albuminuria Is Associated with Traditional Cardiovascular Risk Factors and Viral Load in HIV-Infected Patients in Rural South Africa
por: Wensink, G. Emerens, et al.
Publicado: (2015)

Organoids and metastatic orthotopic mouse model for mismatch repair-deficient colorectal cancer
por: Song, Yurong, et al.
Publicado: (2023)

In vitro chemotherapy-associated muscle toxicity is attenuated with nutritional support, while treatment efficacy is retained
por: Wijler, Liza A., et al.
Publicado: (2022)

Patient-derived pancreatic tumour organoids identify therapeutic responses to oncolytic adenoviruses
por: Raimondi, Giulia, et al.
Publicado: (2020)

Specialized nutrition improves muscle function and physical activity without affecting chemotherapy efficacy in C26 tumour‐bearing mice
por: Wijler, Liza A., et al.
Publicado: (2021)

Organoids from colorectal peritoneal metastases as a platform for improving hyperthermic intraperitoneal chemotherapy
por: Ubink, I., et al.
Publicado: (2019)

CFTR Rescue in Intestinal Organoids with GLPG/ABBV-2737, ABBV/GLPG-2222 and ABBV/GLPG-2451 Triple Therapy
por: de Poel, Eyleen, et al.
Publicado: (2021)

Handcuffing intrinsically disordered regions in Mlh1–Pms1 disrupts mismatch repair
por: Furman, Christopher M, et al.
Publicado: (2021)

Generation and initial characterization of novel tumour organoid models to study human pancreatic cancer‐induced cachexia
por: Vaes, Rianne D.W., et al.
Publicado: (2020)

Consensus molecular subtype 4 (CMS4)-targeted therapy in primary colon cancer: A proof-of-concept study
por: Peters, Niek A., et al.
Publicado: (2022)

Molecular and Functional Characterization of Human Intestinal Organoids and Monolayers for Modeling Epithelial Barrier
por: Jelinsky, Scott A, et al.
Publicado: (2022)

3D kidney organoids for bench-to-bedside translation
por: Gupta✉, Navin, et al.
Publicado: (2020)

Colorectal cancer intrinsic subtypes predict chemotherapy benefit, deficient mismatch repair and epithelial-to-mesenchymal transition
por: Roepman, Paul, et al.
Publicado: (2014)

Nucleotide mismatches prevent intrinsic self-silencing of hpRNA transgenes to enhance RNAi stability in plants
por: Zhang, Daai, et al.
Publicado: (2022)

Does the early social environment prepare individuals for the future? A match-mismatch experiment in female wild cavies
por: Sangenstedt, Susanne, et al.
Publicado: (2018)

Protocol for Application, Standardization and Validation of the Forskolin-Induced Swelling Assay in Cystic Fibrosis Human Colon Organoids
por: Vonk, Annelotte M., et al.
Publicado: (2020)

3D imaging of colorectal cancer organoids identifies responses to Tankyrase inhibitors
por: Badder, Luned M., et al.
Publicado: (2020)

Macrophages induce “budding” in aggressive human colon cancer subtypes by protease-mediated disruption of tight junctions
por: Trumpi, Kari, et al.
Publicado: (2018)

Effects of Notch signalling on the expression of SEMA3C, HMGA2, CXCL14, CXCR7, and CCL20 in breast cancer
por: KÜÇÜKKÖSE, Cansu, et al.
Publicado: (2019)

Defects in mismatch repair: the Achilles heel of estrogen receptor positive breast cancer with intrinsic endocrine therapy resistance?
por: Haricharan, Svasti, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_n9k3rfcf4366v7q0nk3uu7332e